Multiple Clinical Indications of Mifepristone: A Systematic Review

被引:6
|
作者
Mathew, Sharon [1 ]
Ticsa, Maria S. [1 ]
Qadir, Soniya [2 ]
Rezene, Aida [3 ]
Khanna, Deepesh [1 ]
机构
[1] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Fdn Sci, Clearwater, FL 33759 USA
[2] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Med Sch, Clearwater, FL USA
[3] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Osteopath Med, Clearwater, FL USA
关键词
uses of mifepristone; ptsd; psychotic depression; leiomyomas; post-coital contraception; abnormal uterine bleeding; gynecologic and obstetric conditions; abortion pill online; synthetic prostaglandin e1 analog; mifepristone; GLUCOCORTICOID-RECEPTOR ANTAGONIST;
D O I
10.7759/cureus.48372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mifepristone and misoprostol are globally used medications that have become disparaged through the stigmatization of reproductive healthcare. Patients are hindered from receiving prompt treatment in clinical scenarios where misoprostol and mifepristone are the drugs of choice. It is no exaggeration to emphasize that in cases where reproductive healthcare is concerned. The aim of this paper is to discuss the different indications of mifepristone and to delineate where the discrepancy in accessibility arises. For this systematic review, we included publications citing clinical trials involving the use and efficacy of mifepristone published in English within the date range of 2000 to 2023. Five databases were searched to identify relevant sources. These databases are Google Scholar, MEDLINE with full text through EBSCO, and three National Center for Biotechnology Information (NCBI) databases (NCBI Bookshelf, PubMed, and PubMed Central). Twenty-three records were ultimately included in this review. Mifepristone has been shown to have therapeutic effects in the treatment of psychiatric disorders, such as major depressive disorder and psychotic depression. There was a significant decrease in depression and psychiatric rating symptoms for patients taking mifepristone versus placebo with no adverse events. Mifepristone has also been shown to improve treatment course in patients with Cushing's disease (CD) who failed or are unable to undergo surgical treatment. In addition, mifepristone has been shown to be a successful treatment option for adenomyosis and leiomyomas. Patients had a statistically significant decrease in uterine volumes following mifepristone treatment, which aided in the alleviation of other symptoms, such as blood loss and pelvic discomfort. Mifepristone is a synthetic steroid that has immense potential to provide symptomatic relief in patients suffering from a wide array of complicated diseases. Historically, mifepristone has been proven to have an incredible safety profile. While further research is certainly needed, the politicization of its medical use for only one of its many indications has unfortunately led to the willful ignorance of its potential despite its evidence-based safety profile and efficacy.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Indications for the surgical excision of fibroadenomas: systematic review
    Gillette, Dorcie P.
    He, Jing
    Lee, Anne E.
    Chao, Celia
    AME SURGICAL JOURNAL, 2023, 3
  • [42] Psilocybin for clinical indications: A scoping review
    Madden, Kim
    Flood, Breanne
    Shing, Darren Young
    Ade-Conde, Michael
    Kashir, Imad
    Mark, Melanie
    MacKillop, James
    Bhandari, Mohit
    Adili, Anthony
    JOURNAL OF PSYCHOPHARMACOLOGY, 2024, 38 (10) : 839 - 845
  • [43] THIOURACIL - A REVIEW OF ITS CLINICAL INDICATIONS
    BISSELL, GW
    NEW YORK STATE JOURNAL OF MEDICINE, 1945, 45 (15) : 1643 - 1646
  • [44] Review Indications, outcomes, and complications of neoumbilical reconstruction: A systematic review
    Guiotto, M.
    Oranges, C. M.
    Cherubino, M.
    Maruccia, M.
    Tedeschi, P.
    Kalbermatten, D. F.
    Raffoul, W.
    di Summa, P. G.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2024, 88 : 83 - 98
  • [45] Multiple myeloma: clinical features and indications for therapy
    Dispenzieri, A
    Kyle, RA
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 553 - 568
  • [46] Percutaneous Cement Discoplasty in Degenerative Spinal Disease: Systematic Review of Indications, Clinical Outcomes, and Complications
    Fusini, Federico
    Girardo, Massimo
    Aprato, Alessandro
    Masse, Alessandro
    Lorenzi, Alberto
    Messina, Domenico
    Colo, Gabriele
    WORLD NEUROSURGERY, 2022, 168 : 219 - 226
  • [47] Flexural strength and translucency characterization of aesthetic monolithic zirconia and relevance to clinical indications: A systematic review
    Fathy, Salma M.
    Al-Zordk, Walid
    Grawish, Mohammed E.
    Swain, Micheal, V
    DENTAL MATERIALS, 2021, 37 (04) : 711 - 730
  • [48] Off-label indications for mifepristone in gynecology and obstetrics
    Dzuba, Ilana G.
    Grossman, Daniel
    Schreiber, Courtney A.
    CONTRACEPTION, 2015, 92 (03) : 203 - 205
  • [49] Mifepristone: Clinical pharmacology
    Robbins, A
    Spitz, IM
    CLINICAL OBSTETRICS AND GYNECOLOGY, 1996, 39 (02): : 436 - 450
  • [50] Clinical Pharmacokinetics of Mifepristone
    Oskari Heikinheimo
    Clinical Pharmacokinetics, 1997, 33 : 7 - 17